Everest Medicines Statistics
Total Valuation
HKG:1952 has a market cap or net worth of HKD 18.96 billion. The enterprise value is 17.87 billion.
Market Cap | 18.96B |
Enterprise Value | 17.87B |
Important Dates
The last earnings date was Tuesday, March 25, 2025.
Earnings Date | Mar 25, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
HKG:1952 has 324.43 million shares outstanding. The number of shares has increased by 2.51% in one year.
Current Share Class | n/a |
Shares Outstanding | 324.43M |
Shares Change (YoY) | +2.51% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 0.95% |
Owned by Institutions (%) | 11.38% |
Float | 211.45M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 24.94 |
PB Ratio | 4.37 |
P/TBV Ratio | 9.80 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -16.12 |
EV / Sales | 23.76 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -22.54 |
Financial Position
The company has a current ratio of 2.54, with a Debt / Equity ratio of 0.14.
Current Ratio | 2.54 |
Quick Ratio | 2.51 |
Debt / Equity | 0.14 |
Debt / EBITDA | n/a |
Debt / FCF | -0.77 |
Interest Coverage | -35.16 |
Financial Efficiency
Return on equity (ROE) is -23.04% and return on invested capital (ROIC) is -9.60%.
Return on Equity (ROE) | -23.04% |
Return on Assets (ROA) | -9.09% |
Return on Invested Capital (ROIC) | -9.60% |
Return on Capital Employed (ROCE) | -18.73% |
Revenue Per Employee | 1.13M |
Profits Per Employee | -1.67M |
Employee Count | 665 |
Asset Turnover | 0.13 |
Inventory Turnover | 10.77 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +156.92% in the last 52 weeks. The beta is 1.72, so HKG:1952's price volatility has been higher than the market average.
Beta (5Y) | 1.72 |
52-Week Price Change | +156.92% |
50-Day Moving Average | 48.48 |
200-Day Moving Average | 34.13 |
Relative Strength Index (RSI) | 57.45 |
Average Volume (20 Days) | 6,357,135 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:1952 had revenue of HKD 752.03 million and -1.11 billion in losses. Loss per share was -3.45.
Revenue | 752.03M |
Gross Profit | 562.83M |
Operating Income | -830.28M |
Pretax Income | -1.11B |
Net Income | -1.11B |
EBITDA | -713.04M |
EBIT | -830.28M |
Loss Per Share | -3.45 |
Balance Sheet
The company has 1.71 billion in cash and 612.54 million in debt, giving a net cash position of 1.09 billion or 3.37 per share.
Cash & Cash Equivalents | 1.71B |
Total Debt | 612.54M |
Net Cash | 1.09B |
Net Cash Per Share | 3.37 |
Equity (Book Value) | 4.33B |
Book Value Per Share | 13.36 |
Working Capital | 1.30B |
Cash Flow
In the last 12 months, operating cash flow was -723.12 million and capital expenditures -69.60 million, giving a free cash flow of -792.72 million.
Operating Cash Flow | -723.12M |
Capital Expenditures | -69.60M |
Free Cash Flow | -792.72M |
FCF Per Share | -2.44 |
Margins
Gross margin is 74.84%, with operating and profit margins of -110.41% and -147.36%.
Gross Margin | 74.84% |
Operating Margin | -110.41% |
Pretax Margin | -147.36% |
Profit Margin | -147.36% |
EBITDA Margin | -94.82% |
EBIT Margin | -110.41% |
FCF Margin | n/a |
Dividends & Yields
HKG:1952 does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -2.51% |
Shareholder Yield | -2.51% |
Earnings Yield | -5.84% |
FCF Yield | -4.18% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
HKG:1952 has an Altman Z-Score of 2.15. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.15 |
Piotroski F-Score | n/a |